<DOC>
	<DOCNO>NCT02693314</DOCNO>
	<brief_summary>The purpose study determine effect two dos Jarro-Dophilus EPS速 probiotic supplement fecal lactobacillus bifidobacteria number , transit survival administer probiotic strain , fecal microbiota , gastrointestinal function general wellbeing healthy human adult .</brief_summary>
	<brief_title>Evaluation Jarro-Dophilus EPS速 Probiotic Formulations</brief_title>
	<detailed_description>Participants screen use International Physical Activity Questionnaire ( question regard physical activity , include intensity , duration frequency ) inclusion/exclusion criterion . Participants schedule begin 7-day baseline period , participant complete daily questionnaire bowel movement frequency , gastrointestinal symptom wellness . On day 8 , height weight determine . Participants randomize one follow group : Group 1 : Jarro-Dophilus EPS速 ( 5 billion CFU/capsule ) , Group 2 : Jarro-Dophilus EPS速 Higher Potency ( 25 billion CFU/capsule ) , Group 3 : Placebo capsule Study participant continue complete daily online questionnaire throughout 28 day treatment 7 day post treatment . Participants also ask complete weekly questionnaire gastrointestinal symptom ( Gastrointestinal Symptom Rating Scale ) throughout entire study . In addition , participant group ask collect one stool sample baseline , one stool sample week 4 treatment additional sample washout period . Stool sample analyze quantified probiotic bacteria change microbiota . Participants ask return unconsumed supplement end treatment period . Additionally , participant weigh treatment period washout period .</detailed_description>
	<criteria>To participate study must between1850 year age willing height weight measure provide demographic information willing consume probiotic placebo capsule daily 4 week willing provide 3 stool sample study willing complete daily questionnaire regard general gastrointestinal wellness Gastrointestinal Symptom Rating Scale weekly throughout entire 6wk study daily access computer Internet access entire 6wk study willing able provide valid social security study payment purpose willing able provide valid social security study payment purpose willing complete International Physical Activity Questionnaire ( asks report physical activity include intensity , duration frequency ) To participate study must NOT currently take medication constipation diarrhea previously currently treat disease illnesses gastrointestinal disease ( gastric ulcer , Crohn 's , Celiac , ulcerative colitis , etc . ) , chronic disease ( diabetes , kidney disease , etc . ) immunecompromising disease condition ( HIV , AIDS , autoimmune , hepatitis , cancer , transplant patient etc . ) know allergy milk , milk protein , soy , gluten gluten sensitivity take antibiotic within past 4 week prior randomization currently take probiotic supplement unwilling discontinue minimum 2 week prior study start current smoker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Jarro-Dophilus</keyword>
	<keyword>probiotic</keyword>
	<keyword>microbiota</keyword>
	<keyword>gastrointestinal</keyword>
</DOC>